MS Patient Dies from Anti-Drug Antibodies
This report is part of a 12-month Clinical Context series. By John Gever, Senior Editor, MedPage Today Published: February 10, 2013…
BIOGEN IDEC AND ELAN SUBMIT APPLICATIONS FOR FIRST-LINE USE OF TYSABRI IN ANTI-JCV ANTIBODY NEGATIVE PATIENTS WITH MS
– Marketing Applications Supported by Risk Stratification Data – WESTON, Mass. & DUBLIN–(BUSINESS WIRE)–Jan. 16, 2013– Today Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE:…
Stuart Schlossman
Investigators Recruiting for Study of Tysabri in Early Relapsing-Remitting MS
Aug 24, 2012 Summary: U.S. investigators are recruiting 300 people with early relapsing-remitting MSto detect factors that might help better predict which…
Stuart Schlossman
Health Canada approves Biogen Tysabri label change
May 24, 2012 Health Canada has approved a change to the TYSABRI Product Monograph to assist physicians and patients with…
Stuart Schlossman
New Analysis of Risk Stratification for TYSABRI® Published in New England Journal of Medicine
18 May 2012 – Use of Biomarker has Potential to Advance Personalized Treatment for MS Patients – WESTON, MA, USA…
Stuart Schlossman
Tysabri Seems OK for Expectant Mothers with MS
By Ed Susman, Contributing Writer, MedPage Today Published: April 29, 2012 Reviewed by Robert Jasmer, MD; Associate Clinical Professor of Medicine, University of…
Stuart Schlossman
New TYSABRI Data Presented at 64th Annual AAN Meeting Highlight Biogen Idec & Elan Commitment to Improving Outcomes in Multiple Sclerosis
Published April 27, 2012 Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) today announced findings from several studies of TYSABRI® (natalizumab)…
Stuart Schlossman
Patients Drop MS Drug (Tysabri), Face Relapse Risk
This report is part of a 12-month Clinical Context series. By John Gever, Senior Editor, MedPage Today Published: April 25, 2012…
Stuart Schlossman
Patient on Novartis’ multiple sclerosis drug gets rare brain disease – PML…
Published April 13, 2012 The Wall Street Journal BASEL, Switzerland – Novartis said Friday a patient treated with its multiple…
Stuart Schlossman
STRATIFY JCV is a blood test that detects anti-JC virus (JCV) antibodies to help assess the risk of PML in patients with MS
If you are unable to read the HTML email below, please view it online. Visit STRATIFYJCV.com/US to watch an educational…
Stuart Schlossman
